Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing
Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124